Source link : https://newshealth.biz/health-news/drug-targeting-tlrs-in-cutaneous-lupus-looks-good-in-mid-stage-studies/
Cutaneous lupus erythematosus (CLE), which has no specific approved therapies, is believed to be driven by excessive interferon and B-cell activity, which in turn are triggered by Toll-like receptors (TLR) 7 and 8. Enpatoran is a small-molecule oral agent that inhibits TLR 7 and 8. In this part of a phase II trial of enpatoran, […]
The post Drug Targeting TLRs in Cutaneous Lupus Looks Good in Mid-Stage Studies first appeared on News Health.
—-
Author : News Health
Publish date : 2026-05-11 18:40:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8